ArticleJournal of translational medicine2021

Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.

Marco Stellato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.